Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in Adults

ClinicalTrials.gov ID: NCT04625972

Public ClinicalTrials.gov record NCT04625972. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 12:28 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Randomized, Double-blind, Placebo-controlled, Multi-center Study in Adults to Determine the Safety and Efficacy of AZD7442, a Combination Product of Two Monoclonal Antibodies (AZD8895 and AZD1061), for Post-exposure Prophylaxis of COVID-19

Study identification

NCT ID
NCT04625972
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
1,131 participants

Conditions and interventions

Conditions

Interventions

  • AZD7442 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 120 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 1, 2020
Primary completion
Apr 6, 2021
Completion
Jul 24, 2022
Last update posted
Nov 20, 2023

2020 – 2022

United States locations

U.S. sites
50
U.S. states
18
U.S. cities
45
Facility City State ZIP Site status
Research Site Guntersville Alabama 35976
Research Site Tempe Arizona 85284
Research Site Little Rock Arkansas 72205
Research Site Bakersfield California 93309
Research Site Corona California 92882
Research Site Garden Grove California 92844
Research Site Huntington Beach California 92647
Research Site Huntington Park California 90255
Research Site Modesto California 95350
Research Site Coral Gables Florida 33134
Research Site Coral Springs Florida 33071
Research Site Miami Florida 33125
Research Site Miami Florida 33155
Research Site Miami Florida 33175
Research Site Miami Florida 33256
Research Site Miami Lakes Florida 33014
Research Site Miami Lakes Florida 33016
Research Site Miami Springs Florida 33166
Research Site Mt. Dora Florida 32757
Research Site North Miami Florida 33161
Research Site Pembroke Pines Florida 33024
Research Site Pompano Beach Florida 33064
Research Site Tampa Florida 33603
Research Site West Palm Beach Florida 33409
Research Site Atlanta Georgia 30328
Research Site Buford Georgia 30519
Research Site Conyers Georgia 30094
Research Site Chicago Illinois 60607
Research Site Chicago Illinois 60640
Research Site Hazel Crest Illinois 60429-2196
Research Site Noblesville Indiana 46060
Research Site West Des Moines Iowa 50266
Research Site Wichita Kansas 67205
Research Site Owensboro Kentucky 42303
Research Site Bethesda Maryland 20814
Research Site High Point North Carolina 27262
Research Site Wilmington North Carolina 28401
Research Site Orangeburg South Carolina 29118
Research Site Dallas Texas 75235
Research Site El Paso Texas 79930
Research Site Friendswood Texas 77546
Research Site Gonzales Texas 78629
Research Site Harlingen Texas 78550
Research Site Houston Texas 77099
Research Site San Antonio Texas 78215
Research Site Riverton Utah 84096
Research Site Alexandria Virginia 22311
Research Site Portsmouth Virginia 23708
Research Site Richmond Virginia 23226
Research Site Tacoma Washington 98402

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04625972, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 20, 2023 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04625972 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →